145 related articles for article (PubMed ID: 37898854)
1. Prognostic Significance of Neutrophil-Lymphocyte Ratio in Patients of High-Grade Glioma Undergoing Adjuvant Chemoradiation: A Prospective Study.
Sharma P; Medhi PP; Bhattacharyya M; Nath J; Kalita AK
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3487-3494. PubMed ID: 37898854
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract][Full Text] [Related]
4. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis.
Lei YY; Li YT; Hu QL; Wang J; Sui AX
World J Surg Oncol; 2019 Aug; 17(1):152. PubMed ID: 31472673
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
9. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas.
Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X
World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Yang J; Xu H; Guo X; Zhang J; Ye X; Yang Y; Ma X
Sci Rep; 2018 Feb; 8(1):3044. PubMed ID: 29445100
[TBL] [Abstract][Full Text] [Related]
12. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
[TBL] [Abstract][Full Text] [Related]
13. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.
Wang J; Xiao W; Chen W; Hu Y
EXCLI J; 2018; 17():505-512. PubMed ID: 30034313
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
17. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.
Bambury RM; Teo MY; Power DG; Yusuf A; Murray S; Battley JE; Drake C; O'Dea P; Bermingham N; Keohane C; Grossman SA; Moylan EJ; O'Reilly S
J Neurooncol; 2013 Aug; 114(1):149-54. PubMed ID: 23780645
[TBL] [Abstract][Full Text] [Related]
18. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
Yang N; Han X; Yu J; Shu W; Qiu F; Han J
J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
[TBL] [Abstract][Full Text] [Related]
20. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma.
Yan P; Li JW; Mo LG; Huang QR
Medicine (Baltimore); 2021 Nov; 100(47):e27972. PubMed ID: 34964788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
